CODAS syndrome (Cerebral-Oculo-Dento-Auriculo-Skeletal Syndrome) is a rare genetic disorder characterized by a combination of physical and neurological abnormalities. It is caused by a mutation in the POMT1 gene. Symptoms may include intellectual disability, seizures, vision and hearing problems, skeletal abnormalities, and facial dysmorphism.

The symptoms of CODAS syndrome vary from person to person, but may include:

-Developmental delays
-Intellectual disability
-Seizures
-Movement disorders
-Speech and language delays
-Hearing loss
-Vision problems
-Growth delays
-Behavioral issues
-Feeding difficulties
-Sleep disturbances
-Skeletal abnormalities
-Cardiac defects
-Kidney problems

CODAS syndrome is caused by a mutation in the PIK3CA gene. This gene is responsible for producing a protein called phosphatidylinositol-4,5-bisphosphate 3-kinase, which is involved in cell growth and development. Mutations in this gene can lead to the development of CODAS syndrome.

The treatments for CODAS syndrome vary depending on the individual and the severity of the condition. Generally, treatment focuses on managing the physical, cognitive, and behavioral symptoms associated with the syndrome. This may include physical therapy, occupational therapy, speech therapy, and/or behavioral therapy. Medications may also be prescribed to help manage symptoms such as seizures, anxiety, and depression. Additionally, surgery may be recommended to correct any physical deformities or abnormalities.

The primary risk factor for CODAS syndrome is a family history of the disorder. Other risk factors include a history of premature birth, low birth weight, and maternal drug or alcohol use during pregnancy.

At this time, there is no cure for CODAS syndrome. However, there are medications and therapies that can help manage the symptoms. These include physical therapy, occupational therapy, speech therapy, medications to help with seizures, and medications to help with behavioral issues.